US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 2026202520242023
Class II · Moderate risk Terminated

Neonatal TPN Starter Bag

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0413-1 D-0687-2023
Class II · Moderate risk Terminated

Neonatal TPN Starter Bag

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0408-1 D-0686-2023
Class II · Moderate risk Terminated

Neonatal TPN Starter Bag

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0407-1 D-0685-2023
Class II · Moderate risk Terminated

Neonatal TPN Starter Bag

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0406-1 D-0684-2023
Class II · Moderate risk Terminated

Neonatal TPN Starter Bag

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0405-1 D-0683-2023
Class II · Moderate risk Terminated

Neonatal TPN Starter Bag

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0400-1 D-0682-2023
Class II · Moderate risk Terminated

Modified del Nido Microplegia

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0219-1 D-0681-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0218-1 D-0680-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0215-1 D-0679-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0214-1 D-0678-2023
Class II · Moderate risk Terminated

Microplegia Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0213-1 D-0677-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0212-1 D-0676-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0211-1 D-0675-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0210-1 D-0674-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0209-1 D-0673-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0206-1 D-0672-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0205-1 D-0671-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0204-1 D-0670-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0203-1 D-0669-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0202-1 D-0668-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0112-1 D-0667-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0111-1 D-0666-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0107-1 D-0665-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0106-1 D-0664-2023
Class II · Moderate risk Terminated

Cardioplegia Solution

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0105-1 D-0663-2023